chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 15 year old daughter who in April 2008, was vaccinated IM with the first 0.5 mL dose of GARDASIL vaccine. There was no concomitant medication. The patient felt faint after receiving the vaccine. The patient also fainted after additional blood work was done after she received the vaccine. The patient's mother decided that she will not continue the dosing series. Unknown medical attention was sought. The patient recovered the day after the vaccination. Additional information has been requested.
Generalized abdominal pain and treatment. ED visit and hospitalization. This visit was within 6 weeks of receiving the COVID vaccine.
slightly sore right arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (slightly sore right arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to antibiotics (fluoroquinolones and various antibiotics), Sulfonamide allergy (sulfa) and Pre-diabetic.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (slightly sore right arm). At the time of the report, VACCINATION SITE PAIN (slightly sore right arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient had never been diagnosed with/ tested positive for COVID-19.  On 04-Apr-2022, the patient received on Shingles vaccine.  The patient received the first Moderna dose on 08-Feb-2021 and experienced a slightly sore right arm.   Concomitant medication included Shingles vaccine on 04-Apr-2021.  No treatment drug details was reported.
Weakness of legs; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6199) via an unspecified route of administration in the right arm on 13Mar2021 at 13:00 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. It was reported that the patient had relevant medical history and was taking concomitant medications within 2 weeks of vaccination, both were unspecified. The patient had no allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the left arm on 20Feb2021 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced weakness of legs which got lot worse. The event resulted in doctor or other healthcare professional office/clinic visit. On an unknown date, the patient underwent Doppler study and the result was unknown. The clinical outcome of the event weakness of legs was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a nurse practitioner refers to a 12 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 21-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion (incorrect product storage). No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Fever 102.8 Body aches  Joint pain Headache Chills Nausea
No adverse event; 1 ml dose received for dose 1; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (1 ml dose received for dose 1) and NO ADVERSE EVENT (No adverse event) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 prophylaxis.     It was unknown if patient was diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination and up to one month before.  Concurrent medical conditions included Drug allergy (Chloroquine allergy), Penicillin allergy (Penicillins allergy), Anxiety, Hypertension, Eye disorder and Pain. Concomitant products included ALPRAZOLAM for Anxiety, CARVEDILOL for Hypertension, IBUPROFEN and ACETAMINOPHEN for Pain.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter. On 28-Jan-2021, the patient experienced OVERDOSE (1 ml dose received for dose 1). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OVERDOSE (1 ml dose received for dose 1) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for OVERDOSE (1 ml dose received for dose 1).    Patient concomitant medication included Vit C/Vit E Lutein Minerals with indication of eye health, oral, 1 capsule.  No treatment information provided.   This case was linked to MOD-2022-630494, MOD-2022-628728 (Patient Link).
Sore; bruised; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th August 2021, the patient received Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced pain and contusion. On an unknown date, the outcome of the pain and contusion were not recovered/not resolved.   It was unknown if the reporter considered the pain and contusion to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The patient received a Shingles vaccine shot 3 days ago and still had sore and bruised. The follow up would not be possible as no contact details were available.
This spontaneous report has been received from a registered nurse as well as the clinical manager referring to a 44 years old female patient. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided. On 24-JAN-2019 the patient was vaccinated with M-M-R II (0.5 ml, lot number: M045390, batch#: 7002151400, expiration date: 14-NOV-2018, therapy type: rHA (recombinant Human albumin); strength was not provided) subcutaneously for prophylaxis (expired product administered) because the titre shows 0 immunity. The vaccine was reconstituted by unspecified sterile diluent. No adverse events were observed and the patient's doctor was contacted. The nurse reported there is no record of the patient previously receiving M-M-R II.
During post vaccination wait time. Patient noticeably anxious/restless/bouncing legs. Initial assessment patient reported feeling like he had a hot flash and arms and were itchy. Vitals taken every five minutes, potential seizure activity noted, patient positioned for safety on cot. EMS activated, hives noted on left upper shoulder and left side of face. Patient complained of shortness of breath and crying. Patient became pale and LOC and temporary apnea noted, 0.3mg EpiPen administered in left leg x 1 dose, by RN. After administration patient gasped became combative. EMS arrived and patient transported via EMS to ED.
ARM IS RED WARM TO TOUCH AND HAS BLISTERS SWOLLEN. BENADRYL MOTRIN ICE AND ELEVATE. PT IS THROWING UP.
Sore arm starting day after; over period of days (2 weeks) pain worked its way down arm to lower part of  arm (deep pain); 4 inch red area lower part of arm above wrist (persisted for months). Now in the past 3-4 months arm strength less than opposite arm & less then before vaccination, says she can "feel something" in her arm when she uses her arm for exercise, obvious that affected arm weaker
COVID PCR +9/23/21.  Admitted for shortness of breath on Bi-pap.
Eight days post injection, my left arm, at the injection site, started itching and became red, slightly swollen, and itchy.  The red area is 2 inches long by 2.5 inches wide. No fever or any other concerning symptoms.  It just started today,
Arm soreness, body aches, mouth sores starting 24 hours after and continuing 3days. Self treated with Advil
Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, CARVEDILOL and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Tested Positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The reporter was calling on behalf of their husband who received their first dose and tested positive for COVID.  Concomitant product used by the patient also included unspecified statin.  No treatment information was provided.   This case was linked to MOD-2021-071112 (Patient Link).
21 y.o. female who arrived by from on-campus presented to the emergency department for Nausea, face/tongue/distal extremity numbness 5 minutes after receiving Covid vaccine.  Patient states that the symptoms are intermittent and "come in waves."  She states that she was simply sitting in a chair doing nothing on the symptoms started. She does not feel like her tongue is swollen, she has no difficulty with breathing, no new rashes, and her nausea is not persistent.  She has no history of anaphylaxis.  She has no history of food or other allergies, and has never used an EpiPen.  She does not typically have symptoms after receiving injections and is a phlebotomist and does not have fear of needles.  Patient's symptoms resolved within 1 hour of her stay.  She felt well, had no difficulty with breathing, did not notice any development of rashes, abdominal pain, nausea.  She states that her heart rate is typically 80s/90s when she checks it.   After her fluids are complete, and she is observed for 4 hours, patient has no symptoms, and feels safe to go home.
Patient falsified DOB when registering for vaccination, stating the minor's DOB was (date given). Guardian, consented to the vaccination.  A state Department of Health verified with statistical records that the patients actual DOB is (date given) which made the vaccine a contraindication.  No known adverse reactions noted.
PT. REPORTED A BRIEF EPISODE OF "LIGHTHEADINESS, AND TACHYCARDIA" EMS ON SCENE EVALUATED PT.  PT. REPORTS ALL SYMPTOMS RESOLVED WITHIN MINUTES, PT. ABC'S INTACT, WITH NORMAL WOB, LUNGS CLEAR, PT. SYMPTOM FREE,AND DENIES CHEST PAIN OR SOB.  PT. NOT TRANSPORTED, PT. REMAINED IN OBSERVATION FOR FULL 30 MINUTES D/T HX. OF ALLERGIES, PT. DENIES HX. OF ANAPHYLAXIS.
Patient visited vaccine clinic today for third dose of COVID vaccine. Patient states has a history of respiratory issues related to asthma following COVID vaccine. Patient states followed medication regimen as ordered by their HCP before COVID vaccine today. Patient advised to remain in clinic at least 30 minutes after vaccination. Patient received third dose Pfizer Covid vaccine 0.3mL. At around 1000 patient states is having minor tongue swelling and states beginning to feel the need to clear her airways. Patient states she felt that way after receiving her second dose, but that it cleared. Urgent care was notified and patient was advised to schedule visit with Urgent care clinic. Patient transferred over to urgent care clinic and was discharged home after receiving Solumedrol IM and Rx for oral prednisone. .
On 7FEB91 parents took child to clinic ER w/ hx of total body sz, Father said had not been sick; no n/v/d; T39.6, very irritable w/ hacky cough; Small erythematous petechiae on occ; Tx APAP;
Vaccine dose was administered from the vial punctured for > 12 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine dose was administered from the vial punctured for > 12 hours) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine dose was administered from the vial punctured for > 12 hours). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine dose was administered from the vial punctured for > 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.
Patient hospitalized for labor and delivery within 6 weeks of receiving COVID vaccination. Per doctor's notes, she had uncomplicated postpartum course. Baby was 7# 9 ounce male.
On Friday, July 30 in the evening around 5pm, I began experiencing symptoms of fatigue, chills, and body sensitivity while making dinner and so I sat down and rested. My temperature was 99.7. I took ibuprofen 600mg around 8pm and the symptoms resolved. However the same symptoms returned the next evening on July 31 and I also began experiencing shortness of breath in the morning and fluttering heart. I called my doctor on Sunday August 1 to determine course of action. I reported the fatigue symptoms and she suggested that I may be experiencing a delayed reaction to the 2nd dose of covid vaccine which I had received earlier on July 21st.  A COVID is unlikely because I was self-isolating in my home 14days prior to the start of my symptoms.  This morning on August 3 I woke up again with shortness of breath and fluttering heart which have been ongoing all day. I had difficulty washing my hair because of the shortness of breath,. I feel like I need to work harder to get a single breath. I believe these symptoms were caused by the vaccination .
huge red area on upper part of the arm; swelling; itching at injection site; nausea; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (huge red area on upper part of the arm), SWELLING (swelling), VACCINATION SITE PRURITUS (itching at injection site), NAUSEA (nausea) and HEADACHE (slight headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (melons), Seasonal allergy and Asthma.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced NAUSEA (nausea) and HEADACHE (slight headache). On 23-Feb-2021, the patient experienced ERYTHEMA (huge red area on upper part of the arm), SWELLING (swelling) and VACCINATION SITE PRURITUS (itching at injection site). At the time of the report, ERYTHEMA (huge red area on upper part of the arm), SWELLING (swelling), VACCINATION SITE PRURITUS (itching at injection site), NAUSEA (nausea) and HEADACHE (slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided by the reporter.  Treatment information was not provided.
sick, terrible body ache, headache; Terrible body ache; Can't get well; Headache; This is a spontaneous report from a contactable consumer (patient). An unspecified age and gender patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot/batch number was not reported), via an unspecified route of administration in 2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021 patient experienced Sick; Terribly sick; I can't work, I cannot work now because all I am is sick, Terrible body ache, Headache, Can't get well. It was reported that she has been sick since the day injection the night she got sick, of the night of the injection on the 4th, after a month ago she have been sick like that sounding like a sick terrible body ache, headache, then severe med checked she have been to my family doctor, she have been to the emergency room. She don't know what else to do, no one is helping me they don't know what to, what do I do. She was terribly sick, and she was not getting the second one. Her pharmacist has known all this, she 'got all this checked in' and he has told me she need to call on Pfizer number on paper work and let you know that she sick and she can't get well, she don't know what's wrong she mean she have problems with getting sick easy and immune inefficiency (voice not clear), she should never got it, wish she would never got it, did not wanted to get it, pushed in to it by  family because they think that it would make me (voice not clear) from the COVID (Voice not clear). she can't work, she cannot work now because all she was sick.  Comment: Reporter type not probed hence captured by default as consumer or other non-health professional in tab. The outcome of events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Uncontrollable shaking /shivering for approximately 30 to 45 minutes. Shaking/shivering similarly occurred for a much shorter duration (circa  10 - 15 minutes) after the first dose. There was no reaction with the second dose. Took acetaminophen  (2 extra strength caplets) just prior to shaking and shivering beginning associated with the Moderna booster. Also took acetaminophen (2 extra strength caplets) with the  first Moderna dose during  the shaking/shivering.
Next day, after this flu shot, I began feeling flu like symptoms. This got progressively worst & for the next 10 days, I had a moderate case of respiratory infection which included: runny nose, sneezing, coughing, vomiting, achy joints & headaches.
3/27/03 Received primary vaccination (6 pricks) 4/10/03 No take- no problems.  Revaccinated 4/10/03 (15 pricks).  4/12/03 Developed headache and severe fatigue.  Fever 101 on 4/12 & 4/13, along with nausea.  Missed work on 4/14/03 due to extreme fatigue and nausea.  4/15/03 Returned to work- still very fatigued.  Developed chest tightness with 'palpitations', no radiating.  EKG-WNL.  BP 112/70, P 72. Nausea resolved.  No further chest tightness on 4/16/03.  All other symptoms also resolved on 4/16/03.  4/17/03: take read- small but major.
no further ae reported; Temp excursion occurred 11/22/21; This spontaneous report was received from a nurse referring to a 20 years old, male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.  The vaccine was improperly stored on 22-NOV-2021 and on 29-DEC-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously, in the left arm (lot number U010398, expiration date 01-APR-2023); (strength and dose were not provided).  The temperature of storage and time frame of the excursion were 6° to 14° Fahrenheit (F) for 10 minutes and 14° to 46° F, for 3 hours respectively.  If a digital data logger was involved was not reported.  No adverse event.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2201USA003515:
Information has been received from a physician concerning herself who on 18-SEP-2009 was inadvertently vaccinated with a dose of PREVNAR (manufacturer Wyeth) instead of PNEUMOVAX 23.  No adverse symptoms reported.  At the reporting time the outcome was unknown.  Follow up information has been received from the physician reported that she was actually given a dose of PREVNAR (manufacturer Wyeth) inadvertently.  The reporter noted that she would be vaccinated with a dose of PNEUMOVAX 23 in a few months.  No further information is available.
Moderna vial was placed in fridge on 01/01/22. Moderna vial with the lot number of, 041J21A has not undergone a temperature excursion. Patient was administered Moderna booster(0.25ML) on 02/17/22 at 08:45AM. Patient has not reported to Medical Clinic with symptoms at this time.
Extra dose administered; given an expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given an expired dose) and EXTRA DOSE ADMINISTERED (Extra dose administered) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A, 010M20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (given an expired dose). On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Extra dose administered). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (given an expired dose) had resolved. At the time of the report, EXTRA DOSE ADMINISTERED (Extra dose administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported by reporter Treatment information was not provided by reporter